Advertisement
Screener

Quanterix Corporation (QTRX) Restricted Cash and Cash Equivalents

2.5 / 5 stars · 33/66 Roast Me

Quanterix Corporation Restricted Cash and Cash Equivalents

Quanterix Corporation (QTRX) had Restricted Cash and Cash Equivalents of $3.35 million as of 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Balance Sheet › Assets

us-gaap:RestrictedCashAndCashEquivalents · last filed 2026-08-10

  • 2026-06-30: Restricted Cash and Cash Equivalents $3.35M.
  • 2026-03-31: Restricted Cash and Cash Equivalents $3.34M.
  • 2025-12-31: Restricted Cash and Cash Equivalents $3.34M.
  • 2025-09-30: Restricted Cash and Cash Equivalents $3.34M.
Period endRestricted Cash and Cash EquivalentsRestricted Cash and Cash Equivalents as first filed
2026-06-30$3.35M
10-Q · filed 2026-08-10
2026-03-31$3.34M
10-Q · filed 2026-05-06
2025-12-31$3.34M
10-K · filed 2026-03-02
2025-09-30$3.34M
10-Q · filed 2025-11-10
2025-06-30$2.64M
10-Q · filed 2026-08-10
2025-03-31$2.64M
10-Q · filed 2026-05-06
2024-12-31$2.61M
10-K · filed 2026-03-02
2024-09-30$2.61M
10-Q · filed 2025-11-10
2024-06-30$2.61M
10-Q · filed 2025-08-07
2024-03-31$2.60M
10-Q · filed 2025-05-12
2023-12-31$2.60M
10-K · filed 2025-03-17
2023-09-30$2.60M
10-Q · filed 2024-12-26
$2.65M
10-Q · filed 2023-11-08
2023-06-30$2.60M
10-Q/A · filed 2024-12-26
$2.69M
10-Q · filed 2023-08-08
2023-03-31$2.60M
10-Q/A · filed 2024-12-26
$2.92M
10-Q · filed 2024-05-08
2022-12-31$2.60M
10-K/A · filed 2024-12-26
2022-09-30$2.60M
10-Q · filed 2023-11-08
2020-12-31$1.10M
10-K · filed 2021-03-05
2019-12-31$1.10M
10-K · filed 2021-03-05
2018-12-31$1.40M
10-K · filed 2020-03-13
2017-12-31$400.00K
10-K · filed 2019-03-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
EyePoint, Inc. (EYPT)United States$0.314B-3.96
908 Devices Inc. (MASS)United States$0.476B-9.53
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15